Canopy Growth (CGC) Capital Expenditures (2019 - 2025)
Canopy Growth (CGC) reported Capital Expenditures of $3.1 million for Q4 2025, up 257.24% on a YoY basis from $869756.7 in Q4 2024, and up 229.65% sequentially from $942556.5 in Q2 2025.
Canopy Growth (CGC) Capital Expenditures (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Capital Expenditures data on file, last reported at $3.1 million in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 257.24% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $6.8 million (up 17.17% YoY), and the FY2026 full-year result was $3.9 million, down 48.39% from the prior year.
- Capital Expenditures grew to $3.1 million in Q4 2025, from $942556.5 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $102.9 million in Q1 2021 to a low of $50526.4 in Q1 2022.
- A 5-year average of $8.4 million and a median of $1.5 million in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 99.95% in 2022 and surged 4201.17% in 2023, its largest moves.
- Tracing CGC's Capital Expenditures over 5 years: stood at $763189.3 in 2021, then jumped by 80.32% to $1.4 million in 2022, then tumbled by 69.9% to $414278.0 in 2023, then soared by 109.95% to $869756.7 in 2024, then jumped by 257.24% to $3.1 million in 2025.
- Business Quant data shows CGC's Capital Expenditures at $3.1 million in Q4 2025, $942556.5 in Q2 2025, and $869756.7 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.11 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Jun 30, 2025 | 942,556.52 |
| Jun 30, 2025 | 942,556.52 |
| Dec 31, 2024 | 869,756.71 |
| Dec 31, 2024 | 869,756.71 |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 184,786.19 |
| Mar 31, 2024 | 184,786.19 |
| Dec 31, 2023 | 414,278.04 |
| Dec 31, 2023 | 414,278.04 |
| Sep 30, 2023 | 514,692.02 |
| Sep 30, 2023 | 514,692.02 |
| Jun 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Mar 31, 2023 | 2.17 Mn |